Free Trial

Alimera Sciences (ALIM) News Today

$3.10
-0.06 (-1.90%)
(As of 05/21/2024 ET)
HC Wainwright Research Analysts Cut Earnings Estimates for Alimera Sciences, Inc. (NASDAQ:ALIM)
Alimera Sciences, Inc. (NASDAQ:ALIM - Free Report) - Analysts at HC Wainwright decreased their Q3 2024 earnings estimates for Alimera Sciences in a report issued on Thursday, May 16th. HC Wainwright analyst Y. Chen now forecasts that the biopharmaceutical company will post earnings per share of (
Alimera Sciences (NASDAQ:ALIM) Stock Rating Reaffirmed by HC Wainwright
HC Wainwright reissued a "buy" rating and issued a $6.00 price target on shares of Alimera Sciences in a report on Thursday.
Alimera Sciences (NASDAQ:ALIM) Issues Earnings Results, Misses Estimates By $0.08 EPS
Alimera Sciences (NASDAQ:ALIM - Get Free Report) released its quarterly earnings data on Tuesday. The biopharmaceutical company reported ($0.12) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by ($0.08). The business had revenue of $23.01 million during the quarter, compared to analyst estimates of $23.72 million. Alimera Sciences had a negative net margin of 24.93% and a negative return on equity of 130.90%. During the same period in the previous year, the firm posted ($0.71) EPS.
Alimera Sciences Reports First Quarter 2024 Results
Alimera Sciences (ALIM) to Release Earnings on Tuesday
Alimera Sciences (NASDAQ:ALIM) will be releasing earnings before the market opens on Tuesday, May 14, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=591841)
StockNews.com Lowers Alimera Sciences (NASDAQ:ALIM) to Hold
StockNews.com cut Alimera Sciences from a "buy" rating to a "hold" rating in a report on Tuesday.
Alimera Sciences (NASDAQ:ALIM) Stock Rating Upgraded by StockNews.com
StockNews.com upgraded Alimera Sciences from a "hold" rating to a "buy" rating in a research report on Monday.
Alimera Sciences, Inc. (NASDAQ:ALIM) Sees Large Growth in Short Interest
Alimera Sciences, Inc. (NASDAQ:ALIM - Get Free Report) was the recipient of a significant growth in short interest during the month of March. As of March 31st, there was short interest totalling 108,800 shares, a growth of 26.8% from the March 15th total of 85,800 shares. Based on an average daily volume of 81,900 shares, the days-to-cover ratio is presently 1.3 days.
Alimera Sciences (NASDAQ:ALIM) Downgraded by StockNews.com to "Hold"
StockNews.com lowered shares of Alimera Sciences from a "buy" rating to a "hold" rating in a report on Friday.
Alimera Sciences (NASDAQ:ALIM) Lifted to Buy at StockNews.com
StockNews.com upgraded shares of Alimera Sciences from a "hold" rating to a "buy" rating in a research note on Thursday.
Luckie & Company Acquires Marbury Creative Group
Luckie & Co. acquires Atlanta marketing agency
Alimera Sciences, Inc. (NASDAQ:ALIM) Short Interest Update
Alimera Sciences, Inc. (NASDAQ:ALIM - Get Free Report) was the recipient of a significant decline in short interest in March. As of March 15th, there was short interest totalling 85,800 shares, a decline of 27.7% from the February 29th total of 118,600 shares. Based on an average trading volume of 82,500 shares, the days-to-cover ratio is currently 1.0 days.
Alimera Sciences (NASDAQ:ALIM) Receives New Coverage from Analysts at Maxim Group
Maxim Group assumed coverage on Alimera Sciences in a research report on Monday. They issued a "buy" rating and a $10.00 target price for the company.
Alimera Sciences (NASDAQ:ALIM) Stock Price Crosses Above Two Hundred Day Moving Average of $3.53
Alimera Sciences (NASDAQ:ALIM) Stock Crosses Above 200-Day Moving Average of $3.53
Alimera Sciences (NASDAQ:ALIM) Issues Earnings Results
Alimera Sciences (NASDAQ:ALIM - Get Free Report) released its earnings results on Thursday. The biopharmaceutical company reported ($0.07) EPS for the quarter, missing analysts' consensus estimates of $0.02 by ($0.09). The business had revenue of $26.31 million for the quarter, compared to analysts' expectations of $25.10 million. During the same period in the previous year, the company earned ($0.54) earnings per share.
Q4 2023 Alimera Sciences Inc Earnings Call
A Preview Of Alimera Sciences's Earnings
Worth Venture Partners LLC Purchases New Position in Alimera Sciences, Inc. (NASDAQ:ALIM)
Worth Venture Partners LLC purchased a new stake in Alimera Sciences, Inc. (NASDAQ:ALIM - Free Report) in the third quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 593,709 shares of the biopharmaceutical company's stock, valued at approximately $1,84
Alimera Sciences, Inc. (NASDAQ:ALIM) Sees Significant Drop in Short Interest
Alimera Sciences, Inc. (NASDAQ:ALIM - Get Free Report) was the recipient of a significant drop in short interest during the month of February. As of February 15th, there was short interest totalling 276,800 shares, a drop of 9.2% from the January 31st total of 304,900 shares. Based on an average daily volume of 99,500 shares, the short-interest ratio is currently 2.8 days.
Alimera Sciences (ALIM) Set to Announce Earnings on Thursday
Alimera Sciences (NASDAQ:ALIM) will be releasing earnings before the market opens on Thursday, March 7, Zacks reports.
AIGH Capital Management LLC Takes $7.36 Million Position in Alimera Sciences, Inc. (NASDAQ:ALIM)
AIGH Capital Management LLC bought a new position in shares of Alimera Sciences, Inc. (NASDAQ:ALIM - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 2,372,572 shares of the biop
Alimera Sciences (NASDAQ:ALIM) Shares Pass Above 200 Day Moving Average of $3.46
Alimera Sciences (NASDAQ:ALIM) Stock Price Passes Above 200-Day Moving Average of $3.46
Get Alimera Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALIM and its competitors with MarketBeat's FREE daily newsletter.

This Could be Your “Big Money” AI Moment (Ad)

BREAKING: New "Formula" Could Lead to Huge AI Payouts When you click here and see what Elon Musk's new invention does… Investors — including multiple billionaires — are now tapping into a unique AI secret to pocket huge, consistent payouts.

Starting today, you could siphon a new stream of income from this $3 billion pool of cash.

ALIM Media Mentions By Week

ALIM Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ALIM
News Sentiment

0.06

0.43

Average
Medical
News Sentiment

ALIM News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ALIM Articles
This Week

17

2

ALIM Articles
Average Week

Get Alimera Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALIM and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:ALIM) was last updated on 5/21/2024 by MarketBeat.com Staff

From Our Partners